170 related articles for article (PubMed ID: 28811730)
1. Racial Differences in Prostate Cancer Treatment: The Role of Socioeconomic Status.
Watson M; Grande D; Radhakrishnan A; Mitra N; Ward KR; Pollack CE
Ethn Dis; 2017; 27(3):201-208. PubMed ID: 28811730
[TBL] [Abstract][Full Text] [Related]
2. Trends in mortality among Black and White men with prostate cancer in Massachusetts and Pennsylvania: Race and neighborhood socioeconomic position.
Iyer HS; Gomez SL; Chen JT; Trinh QD; Rebbeck TR
Cancer; 2021 Jul; 127(14):2525-2534. PubMed ID: 33798264
[TBL] [Abstract][Full Text] [Related]
3. Racial/ethnic disparities in survival among men diagnosed with prostate cancer in Texas.
White A; Coker AL; Du XL; Eggleston KS; Williams M
Cancer; 2011 Mar; 117(5):1080-8. PubMed ID: 21351084
[TBL] [Abstract][Full Text] [Related]
4. Use of empiric methods to inform prostate cancer health disparities: Comparison of neighborhood-wide association study "hits" in black and white men.
Lynch SM; Sorice K; Tagai EK; Handorf EA
Cancer; 2020 Jan; 126(9):1949-1957. PubMed ID: 32012234
[TBL] [Abstract][Full Text] [Related]
5. A multidimensional view of racial differences in access to prostate cancer care.
Pollack CE; Armstrong KA; Mitra N; Chen X; Ward KR; Radhakrishnan A; Wong MS; Bekelman JE; Branas CC; Rhodes KV; Grande DT
Cancer; 2017 Nov; 123(22):4449-4457. PubMed ID: 28727136
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer in Pennsylvania: The role of older age at diagnosis, aggressiveness, and environmental risk factors on treatment and mortality using data from the Pennsylvania Cancer Registry.
Bluethmann SM; Wang M; Wasserman E; Chen C; Zaorsky NG; Hohl RJ; McDonald AC
Cancer Med; 2020 May; 9(10):3623-3633. PubMed ID: 32212232
[TBL] [Abstract][Full Text] [Related]
7. Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California.
Long B; Chang J; Ziogas A; Tewari KS; Anton-Culver H; Bristow RE
Am J Obstet Gynecol; 2015 Apr; 212(4):468.e1-9. PubMed ID: 25448522
[TBL] [Abstract][Full Text] [Related]
8. Impact of individual and neighborhood factors on disparities in prostate cancer survival.
DeRouen MC; Schupp CW; Koo J; Yang J; Hertz A; Shariff-Marco S; Cockburn M; Nelson DO; Ingles SA; John EM; Gomez SL
Cancer Epidemiol; 2018 Apr; 53():1-11. PubMed ID: 29328959
[TBL] [Abstract][Full Text] [Related]
9. Race differences in mobility status among prostate cancer survivors: The role of socioeconomic status.
Thorpe RJ; Bruce MA; Howard DL; LaVeist TA
Adv Cancer Res; 2020; 146():103-114. PubMed ID: 32241385
[TBL] [Abstract][Full Text] [Related]
10. Hospital racial composition and the treatment of localized prostate cancer.
Pollack CE; Bekelman JE; Liao KJ; Armstrong K
Cancer; 2011 Dec; 117(24):5569-78. PubMed ID: 21692067
[TBL] [Abstract][Full Text] [Related]
11. Changing relationship between socioeconomic status and prostate cancer incidence.
Liu L; Cozen W; Bernstein L; Ross RK; Deapen D
J Natl Cancer Inst; 2001 May; 93(9):705-9. PubMed ID: 11333293
[TBL] [Abstract][Full Text] [Related]
12. When Primary Care Providers (PCPs) Help Patients Choose Prostate Cancer Treatment.
Radhakrishnan A; Grande D; Ross M; Mitra N; Bekelman J; Stillson C; Pollack CE
J Am Board Fam Med; 2017; 30(3):298-307. PubMed ID: 28484062
[TBL] [Abstract][Full Text] [Related]
13. Association Between Socioeconomic Status and Tumor Grade Among Black Men with Prostate Cancer.
Percy-Laurry A; Altekruse SF; Hossain MB; O'Keefe AM; Johnson NJ; Kamangar F
J Natl Med Assoc; 2018 Feb; 110(1):53-57. PubMed ID: 29510844
[TBL] [Abstract][Full Text] [Related]
14. The effect of socioeconomic status, race, and insurance type on newly diagnosed metastatic prostate cancer in the United States (2004-2013).
Weiner AB; Matulewicz RS; Tosoian JJ; Feinglass JM; Schaeffer EM
Urol Oncol; 2018 Mar; 36(3):91.e1-91.e6. PubMed ID: 29153624
[TBL] [Abstract][Full Text] [Related]
15. Neighborhood socioeconomic status and Hodgkin's lymphoma incidence in California.
Clarke CA; Glaser SL; Keegan TH; Stroup A
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1441-7. PubMed ID: 15941953
[TBL] [Abstract][Full Text] [Related]
16. Racial/ethnic disparities in the treatment of localized/regional prostate cancer.
Underwood W; De Monner S; Ubel P; Fagerlin A; Sanda MG; Wei JT
J Urol; 2004 Apr; 171(4):1504-7. PubMed ID: 15017208
[TBL] [Abstract][Full Text] [Related]
17. Sociodemographic Disparities in Cure-Intended Treatment in Localized Prostate Cancer.
des Bordes JKA; Lopez DS; Swartz MD; Volk RJ
J Racial Ethn Health Disparities; 2018 Feb; 5(1):104-110. PubMed ID: 28205153
[TBL] [Abstract][Full Text] [Related]
18. Spatial-temporal analysis of prostate cancer incidence from the Pennsylvania Cancer Registry, 2000-2011.
Wang M; Matthews SA; Iskandarani K; Li Y; Li Z; Chinchilli VM; Zhang L
Geospat Health; 2017 Nov; 12(2):611. PubMed ID: 29239571
[TBL] [Abstract][Full Text] [Related]
19. The Association between Income Status and Treatment Selection for Prostate Cancer in a Universal Health Care System: A Population-Based Analysis.
Oake JD; Harasemiw O; Tangri N; Ferguson TW; Saranchuk JW; Bansal RK; Drachenberg DE; Nayak JG
J Urol; 2021 Nov; 206(5):1204-1211. PubMed ID: 34181467
[TBL] [Abstract][Full Text] [Related]
20. Access to definitive treatment and survival for intermediate-risk and high-risk prostate cancer at hospital systems serving health disparity populations.
Nguyen DD; Labban M; Briggs L; Wallis CJD; Cole AP; Lipsitz SR; Iyer HS; Rebbeck TR; Weissman JS; Choueiri TK; Trinh QD
Urol Oncol; 2023 May; 41(5):252.e9-252.e17. PubMed ID: 36759298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
